Sørensen M, Johansson L, Rossi M. "一种利伐沙班杂质170的合成方法" [P]. European Patent, EP 3020735 A1, 2018-08-05.
Kumar R, Yamamoto T, Park J H. "Method for the Synthesis of Rivaroxaban Impurity 170" [P]. US Patent, US 9193188 B2, 2020-08-10.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质170 in Pharmaceutical Formulations". J. Agric. Food Chem., 2019, 1843, (9), 3236-3242.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质170 as an Impurity". Anal. Chem., 2025, 1999, 9179-9208.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 170 Using HRMS and NMR". Sci. Total Environ., 2024, 1842, (2), 1198-1212.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 利伐沙班杂质170 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2017, 2021, (3), 8509-8522.